Aberrant expression and phosphorylation of beta-catenin in human colorectal cancer
1998

Beta-Catenin in Human Colorectal Cancer

Sample size: 86 publication Evidence: moderate

Author Information

Author(s): T Takayama, H Shiozaki, Y Doki, H Oka, M Inoue, M Yamamoto, S Tamura, S Shibamoto, F Ito, M Monden

Primary Institution: Osaka University Medical School

Hypothesis

The study investigates the expression and phosphorylation of beta-catenin in human colorectal cancer and its correlation with clinicopathological factors.

Conclusion

Reduced expression of beta-catenin is significantly correlated with tumor invasion and metastasis in colorectal cancer tissues.

Supporting Evidence

  • Reduced expression of beta-catenin was observed in 33% of colon cancer tissues.
  • Reduced beta-catenin expression correlated with dedifferentiation and advanced Duke's stages.
  • Beta-catenin phosphorylation was more frequent in cancerous tissues than in normal mucosa.

Takeaway

This study found that in colorectal cancer, lower levels of a protein called beta-catenin are linked to more aggressive cancer behavior.

Methodology

The study used immunohistochemistry to analyze beta-catenin, E-cadherin, and alpha-catenin expression in colorectal cancer tissues.

Participant Demographics

Patients with colorectal cancer who underwent surgery at Osaka University.

Statistical Information

P-Value

<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication